GO:0001409 guanine nucleotide transmembrane transporter activity: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0001409 defines the molecular function that enables transfer of guanine nucleotides (GMP, GDP, and GTP) across a membrane.
This activity is distinct from nucleotide binding or hydrolysis; it specifically describes transmembrane transport of guanine-based nucleotides.
Proteins annotated with this function include members of the mitochondrial carrier family and other solute carriers that mediate guanine nucleotide exchange between cellular compartments.
Dysregulation of guanine nucleotide transport can impact nucleotide pools, signaling, and energy metabolism, with implications for viral infection and cancer.
Experimental approaches such as RNA profiling, transport assays, and CRISPR-based knockout models are used to study genes carrying this activity.
EDITGENE provides CRISPR services to interrogate the function of genes annotated with GO:0001409 in disease-relevant models.

Description

Guanine nucleotide transmembrane transporter activity (GO:0001409) is a molecular function that enables the movement of guanine nucleotides, specifically GMP, GDP, and GTP, from one side of a membrane to the other. This activity is essential for maintaining nucleotide homeostasis within cells and organelles, and it supports processes such as RNA synthesis, signal transduction, and energy transfer. Researchers studying this term are often interested in how cells regulate the distribution of guanine nucleotides and how defects in transport contribute to disease. The function is carried out by integral membrane proteins that form channels or carriers, and it is distinct from enzymes that synthesize or hydrolyze guanine nucleotides. Understanding GO:0001409 is therefore critical for dissecting metabolic and signaling pathways that depend on compartmentalized nucleotide pools.

guanine nucleotide transmembrane transporter activity At A Glance

GO ID GO:0001409
GO term guanine nucleotide transmembrane transporter activity
Ontology molecular_function
Synonym none
Major function Transfer of GMP, GDP, and GTP across a membrane
Definition source QuickGO
Related activity Nucleotide transport, mitochondrial carrier activity
Cellular context Membranes of organelles and cells

What Is GO:0001409?

In simple terms, GO:0001409 describes the job of proteins that move guanine nucleotides across a membrane. The official definition states: Enables the transfer of guanine nucleotides (GMP, GDP, and GTP) from one side of a membrane to the other. This function is classified under molecular_function and does not imply any specific mechanism (e.g., facilitated diffusion or active transport) unless additional evidence is provided.

Why Is guanine nucleotide transmembrane transporter activity Important in Cell Biology?

Guanine nucleotide transmembrane transporter activity is important because it controls the availability of GTP and GDP for signaling and biosynthesis within specific cellular compartments. For example, mitochondrial GTP transport supports protein synthesis and energy metabolism, while cytosolic GTP is required for signal transduction and vesicle trafficking. Disruptions in this activity can lead to altered nucleotide pools, which have been linked to viral replication and cancer cell proliferation. Therefore, studying GO:0001409 helps researchers understand fundamental cell biology and identify therapeutic targets.
Maintains compartmentalized pools of GTP and GDP for signaling and metabolism.
Supports mitochondrial protein synthesis and energy transduction.
Impacts viral replication, as seen in TBEV-infected neurons and astrocytes.
Contributes to drug resistance and proliferation in acute leukemias.
Influences cyclic nucleotide signaling pathways.
Plays a role in secretory diarrhea through CFTR-related transport.
Affects nociceptor signaling via guanylyl cyclase receptors.
Provides a target for CRISPR-based functional studies.

What Happens During guanine nucleotide transmembrane transporter activity?

Substrate recognition and binding
In simple terms: The transporter first grabs the guanine nucleotide it needs to move.
Transporter proteins recognize GMP, GDP, or GTP through specific binding pockets that discriminate guanine from other nucleotides. This step ensures selectivity and is often coupled to conformational changes in the protein.
Translocation across the membrane
In simple terms: The nucleotide is then shuttled through the membrane.
Following binding, the transporter undergoes structural rearrangements that allow the nucleotide to pass through the lipid bilayer. This process may be facilitated by concentration gradients or energy-dependent mechanisms, depending on the specific transporter.
Release and recycling
In simple terms: Once across, the nucleotide is released and the transporter resets.
The nucleotide is released on the other side of the membrane, and the transporter returns to its initial state to repeat the cycle. This cycle is essential for maintaining steady-state nucleotide pools.
Integration with cellular metabolism
In simple terms: The transported nucleotides feed into many cellular processes.
Guanine nucleotides delivered by these transporters participate in RNA synthesis, protein synthesis, and signal transduction. Their availability can influence viral replication and cancer cell growth.

Key Genes Involved in GO:0001409 guanine nucleotide transmembrane transporter activity

The following genes encode proteins that have been associated with guanine nucleotide transmembrane transporter activity or related transport functions, based on published literature.
GeneMajor RoleResearch Relevance
SLC25AMitochondrial carrier familyTransport of nucleotides across mitochondrial membrane
RAB8Vesicle traffickingUnconventional protein secretion
RAB11Vesicle traffickingUnconventional protein secretion
CNGACyclic nucleotide-gated channelCyclic nucleotide transport and signaling
ABCCATP-binding cassette transporterDrug transport and resistance
CFTRChloride channelSecretory diarrhea and ion transport
GUCYGuanylyl cyclase receptorCyclic GMP signaling
NPR2Guanylyl cyclase receptorNociceptor signaling and pain
SLC25A4Mitochondrial carrierNucleotide transport
SLC25A5Mitochondrial carrierNucleotide transport
SLC25A6Mitochondrial carrierNucleotide transport
SLC25A10Mitochondrial carrierNucleotide transport
SLC25A11Mitochondrial carrierNucleotide transport
SLC25A12Mitochondrial carrierNucleotide transport
SLC25A13Mitochondrial carrierNucleotide transport
SLC25A14Mitochondrial carrierNucleotide transport
SLC25A15Mitochondrial carrierNucleotide transport

How Is guanine nucleotide transmembrane transporter activity Regulated?

The activity of guanine nucleotide transmembrane transporters can be regulated at multiple levels, including transcriptional control, post-translational modifications, and interaction with partner proteins. For example, RAB-8 and RAB-11 coordinate unconventional protein secretion, which may influence nucleotide transport indirectly. Additionally, cyclic nucleotide-gated channels are regulated by cyclic nucleotides and voltage. However, specific regulatory mechanisms for many transporters remain to be fully elucidated.

guanine nucleotide transmembrane transporter activity and Human Disease

GeneDisease / BiologyPotential Experimental Model
SLC25AMitochondrial dysfunctionKnockout in cell lines
ABCCAcute leukemiaOverexpression and drug resistance assays
CFTRSecretory diarrheaKnockout in intestinal cells
NPR2Chronic painKnockout in nociceptors
RAB8/RAB11Protein secretion defectsKnockdown in cultured cells
Viral infections
Guanine nucleotide transport may be hijacked by viruses such as TBEV to support replication, as suggested by RNA profiling of infected neurons and astrocytes. Targeting these transporters could reduce viral propagation.
Cancer
Altered nucleotide transport contributes to drug resistance in acute leukemias, where cyclic nucleotide transporters are potential therapeutic targets. Modulating these transporters may enhance chemotherapy efficacy.
Secretory diarrhea
CFTR, a chloride channel, is involved in drug-induced secretory diarrhea, and its function is linked to nucleotide transport and signaling. Understanding these pathways can inform treatments.
Pain and nociception
Npr2, a guanylyl cyclase receptor, contributes to acute and persistent pain through nociceptor-specific signaling, which may involve cyclic nucleotide transport.

From guanine nucleotide transmembrane transporter activity-Related Genes to Experimental Models

Research QuestionSuitable Model
Does gene X transport GTP?Knockout cell line
What is the effect of point mutation on transport?Point mutation knock-in
Can we tag the transporter for imaging?Tagged knock-in
Does overexpression alter nucleotide pools?Overexpression cell line
Which genes are essential for transport?CRISPR library screening
How does transport affect viral replication?Infected cell models

How to Study the guanine nucleotide transmembrane transporter activity Process

MethodWhat It MeasuresTypical Application
RNA-seqGene expressionIdentify transporter genes
Transport assayNucleotide uptakeMeasure activity
ProteomicsProtein interactionsFind regulators
Live-cell imagingLocalizationTrack transporters
CRISPR knockoutGene functionLoss-of-function studies
CRISPR knock-inTagged proteinsImaging and pull-down
Library screeningEssential genesIdentify candidates
RNA profiling
RNA sequencing can reveal expression changes in transporter genes under different conditions, such as viral infection.
Transport assays
Radioactive or fluorescent nucleotide uptake assays measure transport activity directly in cells or vesicles.
Proteomics
Mass spectrometry can identify interacting partners and post-translational modifications of transporters.
Imaging
Fluorescent tagging allows visualization of transporter localization and dynamics in live cells.

How CRISPR Can Be Used to Study GO:0001409 guanine nucleotide transmembrane transporter activity

Knockout

CRISPR knockout can eliminate transporter genes to assess their role in nucleotide transport and cellular phenotypes.

Point Mutation

Introducing point mutations can mimic disease-associated variants and test their impact on transport activity.

Knock-in

Knock-in of tags or reporters enables visualization and biochemical isolation of transporters.

Overexpression

Overexpression models can study gain-of-function effects and nucleotide pool changes.

How EDITGENE Supports guanine nucleotide transmembrane transporter activity Research

Researchers studying guanine nucleotide transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in transport, signaling, or disease. EDITGENE provides CRISPR-based services to create precise cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for guanine nucleotide transmembrane transporter activity research.

Frequently Asked Questions About guanine nucleotide transmembrane transporter activity

It is a molecular function that enables the transfer of GMP, GDP, and GTP across a membrane.
Genes such as SLC25A family members, RAB8, RAB11, and CFTR have been associated with related transport functions.
The GO ID is GO:0001409.
Researchers use RNA profiling, transport assays, proteomics, and CRISPR models.
It affects viral replication, cancer drug resistance, and secretory diarrhea.
Yes, CRISPR knockout, knock-in, and point mutation models are valuable for functional studies.
The substrates are GMP, GDP, and GTP.
Yes, it is classified under molecular_function in the Gene Ontology.
Acute leukemias, viral infections, and pain disorders have been linked.
EDITGENE offers CRISPR services including knockout, point mutation, knock-in, overexpression, and library screening.

Conclusion

Guanine nucleotide transmembrane transporter activity (GO:0001409) is a fundamental molecular function that controls the movement of GMP, GDP, and GTP across membranes, impacting metabolism, signaling, and disease. Continued research using CRISPR and other tools will clarify its roles and therapeutic potential.

References

  1. 1. Selinger M et al.. 2022. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors.. Comput Struct Biotechnol J 20:2759-2777 PMID: 35685361
  2. 2. Li X et al.. 2024. Coordination of RAB-8 and RAB-11 during unconventional protein secretion.. J Cell Biol 223(2) PMID: 38019180
  3. 4. Li M et al.. 2017. Structure of a eukaryotic cyclic-nucleotide-gated channel.. Nature 542(7639):60-65 PMID: 28099415
  4. 5. Perez DR et al.. 2021. Drug repurposing for targeting cyclic nucleotide transporters in acute leukemias - A missed opportunity.. Semin Cancer Biol 68:199-208 PMID: 32044470
  5. 6. Moon C et al.. 2015. Drug-induced secretory diarrhea: A role for CFTR.. Pharmacol Res 102:107-112 PMID: 26429773
  6. 7. Kuhn M. 2016. Molecular Physiology of Membrane Guanylyl Cyclase Receptors.. Physiol Rev 96(2):751-804 PMID: 27030537
  7. 8. Gerninghaus H et al.. 2025. Nociceptor-specific signaling of the receptor guanylyl cyclase Npr2 contributes to acute and persistent pain.. Sci Signal 18(889):eadq4238 PMID: 40460194
Contact Us
*
*
*
*
How did you hear about us: